0

Journal Articles

in Cardiothoracic Surgery
 21-40 of 292 Articles
JAMA | 
Editorial |  August 01, 2012
Endoscopic Vein-Graft Harvest Is Safe for CABG Surgery
Lawrence J. Dacey, MD, MS
JAMA. 2012;308(5):512-513. doi:10.1001/jama.2012.9079.
JAMA Internal Medicine | 
Invited Commentary |  June 11, 2012
Routine Periodic Stress Testing in Asymptomatic Patients Following Coronary Revascularization: Is It Worth the Effort?:  Comment on “Exercise Testing in Asymptomatic Patients After Revascularization”
Mark J. Eisenberg, MD, MPH
Arch Intern Med. 2012;172(11):861-863. doi:10.1001/archinternmed.2012.1910.
JAMA Internal Medicine | 
Original Investigation |  June 11, 2012
Exercise Testing in Asymptomatic Patients After Revascularization:  Are Outcomes Altered?
Serge C. Harb, MD; Thomas Cook, MPH, PhD; Wael A. Jaber, MD; et al.
Arch Intern Med. 2012;172(11):854-861. doi:10.1001/archinternmed.2012.1355.
JAMA Internal Medicine | 
Invited Commentary |  June 11, 2012
Activating Primary Percutaneous Coronary Intervention for STEMI That Is Not: The Collateral Damage of Improving Door-to-Balloon Time:  Comment on “Prevalence and Factors Associated With False-Positive ST-Segment Elevation Myocardial Infarction Diagnoses at Primary Percutaneous Coronary Intervention–Capable Centers”
Fouad Bachour, MD; Richard Asinger, MD
Arch Intern Med. 2012;172(11):871. doi:10.1001/archinternmed.2012.1117.
JAMA Internal Medicine | 
Original Investigation |  June 11, 2012
Prevalence and Factors Associated With False-Positive ST-Segment Elevation Myocardial Infarction Diagnoses at Primary Percutaneous Coronary Intervention–Capable Centers:  A Report From the Activate-SF Registry
James M. McCabe, MD; Ehrin J. Armstrong, MD, MSc; Ameya Kulkarni, MD; et al.
Arch Intern Med. 2012;172(11):864-871. doi:10.1001/archinternmed.2012.945.
JAMA Internal Medicine | 
Invited Commentary |  March 26, 2012
Interpreting Biomarkers During Percutaneous Coronary Intervention: The Need to Reevaluate Our Approach:  Comment on “Troponin Criteria for Myocardial Infarction After Percutaneous Coronary Intervention”
Joseph S. Alpert, MD; Allan S. Jaffe, MD
Arch Intern Med. 2012;172(6):508-509. doi:10.1001/archinternmed.2011.2284.
JAMA Internal Medicine | 
Challenges in Clinical Electrocardiography |  March 12, 2012
Significance of ST-Segment Elevation in Lead aVR
Kenta Nakamura, MD; Natalia C. Berry, MD; Perry G. An, MD; et al.
Arch Intern Med. 2012;172(5):389. doi:10.1001/archinternmed.2011.2224.
JAMA Internal Medicine | 
Challenges in Clinical Electrocardiography |  March 12, 2012
Discussion
Arch Intern Med. 2012;172(5):390-391. doi:10.1001/archinte.172.5.390.
JAMA Internal Medicine | 
Invited Commentary |  February 27, 2012
Mounting Evidence for Lack of PCI Benefit in Stable Ischemic Heart Disease:What More Will It Take to Turn the Tide of Treatment?:  Comment on "Initial Coronary Stent Implantation With Medical Therapy vs Medical Therapy Alone for Stable Coronary Artery Disease"
William E. Boden, MD
Arch Intern Med. 2012;172(4):319-321. doi:10.1001/archinternmed.2011.2321.
JAMA Internal Medicine | 
Original Investigation |  February 27, 2012 FREE
A Randomized Controlled Trial of Positive-Affect Induction to Promote Physical Activity After Percutaneous Coronary Intervention
Janey C. Peterson, EdD, MS, RN; Mary E. Charlson, MD; Zachary Hoffman, BS; et al.
Arch Intern Med. 2012;172(4):329-336. doi:10.1001/archinternmed.2011.1311.
JAMA Internal Medicine | 
Editorial |  January 23, 2012
Reconsidering Transfer for Percutaneous Coronary Intervention Strategy:  Time Is of the Essence
Rita F. Redberg, MD, MSc
Arch Intern Med. 2012;172(2):98-99. doi:10.1001/archinternmed.2011.566.
JAMA Internal Medicine | 
Invited Commentary |  January 23, 2012
Prediction Is Very Hard, Especially About the Future:  Comment on “Factors Associated With 30-Day Readmission Rates After Percutaneous Coronary Intervention”
Adrian F. Hernandez, MD, MHS; Christopher B. Granger, MD
Arch Intern Med. 2012;172(2):117-119. doi:10.1001/archinternmed.2011.568.
JAMA Internal Medicine | 
Original Investigation |  January 23, 2012 FREE
Factors Associated With 30-Day Readmission Rates After Percutaneous Coronary Intervention
Farhan J. Khawaja, MD; Nilay D. Shah, PhD; Ryan J. Lennon, MS; et al.
Arch Intern Med. 2012;172(2):112-117. doi:10.1001/archinternmed.2011.569.
JAMA Internal Medicine | 
Special Article |  January 23, 2012
Overuse of Health Care Services in the United States:  An Understudied Problem
Deborah Korenstein, MD; Raphael Falk, MD, MPH; Elizabeth A. Howell, MD, MPP; et al.
Arch Intern Med. 2012;172(2):171-178. doi:10.1001/archinternmed.2011.772.
INCLUDES: , Supplemental Content
JAMA | 
Original Contribution |  January 18, 2012 FREE
Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery:  A Randomized Controlled Trial
Dominick J. Angiolillo, MD, PhD; Michael S. Firstenberg, MD; Matthew J. Price, MD; et al.
JAMA. 2012;307(3):265-274. doi:10.1001/jama.2011.2002.
INCLUDES: , Supplemental Content
JAMA | 
Editorial |  December 14, 2011
The Trials and Tribulations of Percutaneous Coronary Intervention in Hospitals Without On-site CABG Surgery
Scott Kinlay, MBBS, PhD
JAMA. 2011;306(22):2507-2509. doi:10.1001/jama.2011.1824.
JAMA Internal Medicine | 
Correction |  November 28, 2011
Errors in Data Reporting in: The Magnitude of Acute Serum Creatinine Increase After Cardiac Surgery and the Risk of Chronic Kidney Disease, Progression of Kidney Disease, and Death
Arch Intern Med. 2011;171(21):1919. doi:10.1001/archinternmed.2011.597.
JAMA Internal Medicine | 
Research Letters |  November 28, 2011 FREE
Prognostic Impact of Hospital Readmissions After Primary Percutaneous Coronary Intervention
Gianluca Campo, MD; Francesco Saia, MD, PhD; Paolo Guastaroba, MSc; et al.
Arch Intern Med. 2011;171(21):1948-1949. doi:10.1001/archinternmed.2011.536.
JAMA Internal Medicine | 
Editor's Correspondence |  November 28, 2011
Percutaneous Coronary Intervention for Persistent Occlusion of the Infarct-Related Artery: An Expanded View of the Evidence—Reply
Judith S. Hochman, MD; Christopher E. Buller, MD
Arch Intern Med. 2011;171(21):1962-1963. doi:10.1001/archinternmed.2011.552.
JAMA Internal Medicine | 
Original Investigation |  November 28, 2011 FREE
National Performance on Door-In to Door-Out Time Among Patients Transferred for Primary Percutaneous Coronary Intervention
Jeph Herrin, PhD; Lauren E. Miller, MS; Dima F. Turkmani, MPH, MBA; et al.
Arch Intern Med. 2011;171(21):1879-1886. doi:10.1001/archinternmed.2011.481.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Medical News and Perspectives  |  April 17, 2013
Two Specialty Societies to Run Their Own Clinical Trial of Heart Valve Replacement
Mike Mitka, MSJ
JAMA
Editorial  |  April 03, 2013
Preventing Postoperative Staphylococcus aureus Infections:  The Search Continues
Preeti N. Malani, MD, MSJ
JAMA
Original Contribution  |  April 03, 2013
Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery:  A Randomized Trial
Vance G. Fowler, MD, MHS; Keith B. Allen, MD; Edson D. Moreira, MD, MPH, PhD; et al.
JAMA Surgery
Original Article  |  February 20, 2013
Protective Effects of Tranexamic Acid on Clopidogrel Before Coronary Artery Bypass Grafting:  A Multicenter Randomized Trial
Jia Shi, MD; Hongwen Ji, MD; Facheng Ren, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems